Positive correlation of LOX and VEGF expression levels, dose-dependent upregulation of both by TGF-β, and under siRNA LOX conditions, decreased VEGF and p38 MAP signaling were noted in hepatocellular carcinoma cells [26]. Here, VEGFA is linked to hepatocellular carcinoma.